# Yalla Group Ltd: financial statements, quarterly

YALA · NYSE · CIK 1794350 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/yala.md) · [Financials](/companies/yala/financials.md) · [Filings](/companies/yala/filings.md) · [Insiders](/companies/yala/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/yala/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2017-12-31) | period not labelled (2018-12-31) | period not labelled (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.9](/filings/0001193125-21-104578.md) | [17.0](/filings/0001193125-21-104578.md) | [45.3](/filings/0001193125-21-104578.md) | [237](/filings/0000950170-22-006105.md) | [351](/filings/0000950170-24-046629.md) | [407](/filings/0000950170-25-056954.md) | [312](/filings/0001193125-26-168267.md) | [488](/filings/0001193125-26-168267.md) | [527](/filings/0001193125-26-168267.md) |
| Current assets | $m | not reported | not reported | [53.5](/filings/0001193125-21-104578.md) | [253](/filings/0000950170-22-006105.md) | [376](/filings/0000950170-23-013563.md) | [482](/filings/0000950170-24-046629.md) | [569](/filings/0000950170-25-056954.md) | [692](/filings/0001193125-26-168267.md) | [796](/filings/0001193125-26-168267.md) |
| Total assets | $m | not reported | not reported | [54.1](/filings/0001193125-21-104578.md) | [255](/filings/0000950170-22-006105.md) | [381](/filings/0000950170-23-013563.md) | [506](/filings/0000950170-24-046629.md) | [639](/filings/0000950170-25-056954.md) | [802](/filings/0001193125-26-168267.md) | [896](/filings/0001193125-26-168267.md) |
| Current liabilities | $m | not reported | not reported | [8.3](/filings/0001193125-21-104578.md) | [21.1](/filings/0000950170-22-006105.md) | [44.7](/filings/0000950170-23-013563.md) | [65.0](/filings/0000950170-24-046629.md) | [75.3](/filings/0000950170-25-056954.md) | [102](/filings/0001193125-26-168267.md) | [88.3](/filings/0001193125-26-168267.md) |
| Total liabilities | $m | not reported | not reported | [8.3](/filings/0001193125-21-104578.md) | [21.1](/filings/0000950170-22-006105.md) | [44.9](/filings/0000950170-23-013563.md) | [66.5](/filings/0000950170-24-046629.md) | [76.3](/filings/0000950170-25-056954.md) | [104](/filings/0001193125-26-168267.md) | [94.2](/filings/0001193125-26-168267.md) |
| Shareholders' equity | $m | [2.0](/filings/0001193125-21-104578.md) | [(7.1)](/filings/0001193125-21-104578.md) | [19.9](/filings/0001193125-21-104578.md) | [234](/filings/0000950170-22-006105.md) | [336](/filings/0000950170-23-013563.md) | [441](/filings/0000950170-24-046629.md) | [568](/filings/0000950170-25-056954.md) | [704](/filings/0001193125-26-168267.md) | [810](/filings/0001193125-26-168267.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.